Noteworthy - April 2021

April 26, 2021 Providence inScope Content Team

Providence Heart Institute news

Collaborative heart series – CME webinars
Providence Heart Institute presents monthly educational programs to support evidence-based diagnosis and management of heart disease with a team-based approach. CME credit is available. More info here>>

Vascular surgery expansion at Providence Heart Institute
Providence Vascular Surgery Program has expanded to include new providers and services to meet the needs of patients with vascular disease. Read the announcement here>>

TAVR research published
Members of Providence Heart Institute’s Valve Program recently completed a manuscript that was published as the largest single center experience with Transcatheter Aortic Valve Replacement (TAVR) in literature. Providence has performed more than 2,000 TAVR procedures. It is one of the highest-volume TAVR sites in the country and the highest volume site in Oregon.
https://www.sciencedirect.com/science/article/pii/S1043067921001222?dgcid=author

Providence Cancer Institute news

3 melanoma studies
The incidence of melanoma is increasing faster than other skin cancers. Providence Cancer Institute is one of a few centers in the Pacific Northwest to offer three new studies of postoperative adjuvant immunotherapy for high-risk melanoma.
https://blog.providence.org/cancer/melanoma-studies-can-adjuvant-immunotherapy-improve-recurrence-free-survival

New provider in Providence Liver Cancer Clinic

Jon Gerry, M.D., is a newly hired provider in the Franz Liver Cancer Clinic at Providence Cancer Institute. He attended medical school at Harvard University, residency at Stanford University, and a fellowship in hepato-pancreato-biliary surgery at Providence Portland Medical Center.

Attend Creating Hope: Stories of Good
Please consider participating in this year’s Creating Hope dinner to support cancer research and programs at Providence Cancer Institute. The virtual event will be held at 7 p.m., Wednesday, May 19. Registration is free. The evening will feature stories of hope from leading researchers, physicians and cancer survivors as they fight to finish cancer. Learn more>>

Honoring nurses and all health care workers in May
With deep gratitude for nurses, hospital caregivers and all health care workers, Providence celebrates National Nurses Week May 6-12 and National Hospital and Health Care Week May 9-15. The 2021 recognition weeks offer opportunities to thank caregivers for their outstanding contributions and unwavering support, especially during challenging times.

Providence pediatrics CME series: May-July
Providence Virtual Pediatric Grand Rounds providers and caregivers who care for children are invited to virtual educational offerings with pediatric specialists. Topics include: Type 1 diabetes update, feeding and breathing disorders, and children and COVID. Learn more>>

Free ‘DocTalks’ to feature range of clinical topics
DocTalks is a new monthly virtual speaker series where participants will hear from Providence physicians who are leading the way in care throughout Oregon. Topics include How Childhood Brain Development Affects Us as Adults, Heart Failure Treatments – When Less is More, Advancements in Neurosurgery and more. DocTalks began in April and run through October. It’s free to join, and all are welcome. Register to reserve your virtual seat today.
https://give.providencefoundations.org/doctalks

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Noteworthy - April 2021

About the Author

Previous Article

Next Article

Noteworthy - April 2021

About the Author

Previous Article

Next Article

Other content in this Stream

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

Free educational presentations from Providence Senior Health are taking place in September in Beaverton, Hillsboro, Seaside and Medford. See the schedule and registration information.

Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

Hospice volunteers offer respite to family members, care for patients at the end of their lives and help people navigate grief. Learn about their service and how to volunteer.

“For my patients.” “For my friend’s daughter.” “For the challenge.” “For the cure.” Providence runners and walkers share why they’re doing the relay – and helping raise funds to #FINISHCANCER.

Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Cancer survivor Mark Williams chats with Dr. Brendan Curti about

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

In 2023, Providence in Oregon did so much to make sure that essential resources – such as health care, food and shelter – were more readily available to the people of our state.

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Walk in the shoes of security officer Patricia Varela and her K-9 partner Nix, and experience their important work to keep everyone safe at Providence Portland Medical Center.

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

This morning, six Providence hospitals in Oregon welcomed our nurses back as we began working together again.